All 7 profitable oil price prediction accounts bet $2,000 each that crude oil will reach $120 by the end of March.
According to PolyBeats monitoring, on the prediction market Polymarket, an account that has made profits in all 7 previous oil price-related predictions invested $2,000 to buy "Yes" in the market "Will crude oil reach $120 before the end of March", with the current probability at 25%.
After Israel launched a military strike on Iran's oil infrastructure yesterday, Trump posted that the US was not aware of this operation. His post specifically pointed out that Israel did not notify or coordinate with the US in advance before carrying out this action targeting energy facilities.
Regarding the progress of the strategic petroleum reserve release, the US government officially launched a plan in mid-March to release a total of 172 million barrels, with approximately 10 million barrels being released to the market each week according to the plan.
Note: Based on the trading profile, this trader is not betting on whether the event actually happens, but may take profit or stop loss at a certain point after opening a position.
Account:
0xefb3247a575c3e78304ec106ddafefefa5b702bf.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Analyst Gu Jingci: Follow the trend and adapt flexibly

XRP Ledger adds account control feature, enabling enterprises to manage assets offline.

BUZZ - Goldman Sachs says the price cap on cancer drugs has limited impact on Indian hospitals
October 9 – Goldman Sachs pointed out that India's implementation of a 30% profit margin cap on non-scheduled anticancer drugs (link) will have limited impact on hospitals. The report states that, based on preliminary discussions with hospital chain groups, such drugs account for less than 5% of hospital revenue and 2% to 2.5% of operating profit. The report adds that hospitals can offset the losses by slightly adjusting service charges, such as administration fees. According to a government notice, an expert committee will finalize the list of drugs to be brought under regulation. Driven by the anticipated price cap, the share prices of Max Healthcare MAXE.NS, Apollo Hospitals APLH.NS, and Fortis Healthcare FOHE.NS rose by 1.6% to 2.5%. Previously, since September 30, these stocks had collectively declined by 11% to 11.5%. Year-to-date, FOHE and MAXE are down 11.7% and 14.8%, respectively, while APLH has risen by 11%. (To assist non-English speakers, Reuters provides automated translations of its reports into several other languages. Due to potential errors or missing context in automated translations, Reuters does not guarantee the accuracy of automatic translation texts and offers them solely for readers’ convenience. Reuters accepts no responsibility for any damage or loss caused by using these automated translation features.)

Adding insult to injury! Japanese electronics giant Nidec downgraded by UBS, stock price plunges over 9% and approaches an 11-month low
UBS has downgraded Nidec's rating from "Buy" to "Neutral" and lowered its target price from 2,800 yen to 2,400 yen, citing a more challenging market environment.
